HT-1 - PULMONARY HYPERTENSION DEMYSTIFIED: DISTINGUISHING GROUP 1 AND GROUP 2 IN CLINICAL PRACTICE

Pulmonary hypertension (PH) presents a complex clinical challenge, particularly when distinguishing between Group 1 (pulmonary arterial hypertension) and Group 2 (PH due to left heart disease).

This session, led by a leading cardiology expert in PH, will demystify the classification and clinical nuances of these conditions. Attendees will gain a clear understanding of the PH groups, including prevalence, incidence, and current treatment strategies, with a focus on Groups 1 and 2. The talk will also cover essential information required for effective referral to specialized PH Centers of Excellence, ensuring timely diagnosis and management. Finally, the session will highlight the importance of multidisciplinary collaborative care models in optimizing outcomes for patients with pulmonary arterial hypertension.

This presentation is designed for cardiologists across Canada, whether or not they currently manage PH patients, providing practical insights to enhance clinical practice and patient care.